Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Dr Reddys Laboratories ADR repsg 1 Ord Shs RDY

Healthcare
Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company. The Company offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC). Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. The... see more

Recent & Breaking News (NYSE:RDY)

Dr. Reddy's Q3 and 9M FY16 Financial Results

Business Wire February 9, 2016

Promius Pharma(TM) Receives FDA Approval for Sernivo (betamethasone dipropionate) Spray, 0.05%

Business Wire February 7, 2016

Dr. Reddy's Laboratories Ltd. receives FDA approval for ZEMBRACE(TM)SymTouch(TM) (sumatriptan succinate) Injection for the acute treatment of migraines in adults

PR Newswire February 2, 2016

SHAREHOLDER ALERT: Scott + Scott, LLP Investigating Dr. Reddy's Labs (RDY) for Possible Securities Fraud

Business Wire February 1, 2016

Dr. Reddy's Laboratories Receives USFDA Tentative Approval for Zenavod(TM) (doxycycline) Capsules, 40 mg for the Treatment of Rosacea in Adults

Business Wire February 1, 2016

Dr. Reddy's Laboratories Ltd. Receives FDA Approval for ZEMBRACE(TM)SymTouch(TM) (sumatriptan succinate) Injection for the Acute Treatment of Migraines in Adults

Business Wire January 29, 2016

Dr. Reddy's to Release Q3FY16 Results on Feb 9, 2016; Earnings Call Slated for Feb 9, 6:30 PM IST / 8:00 AM EST

Business Wire January 28, 2016

Lifshitz & Miller Law Firm Announces Investigation of BofI Holding, Inc., Capstone Turbine Corporation, Dr. Reddy's Laboratories Ltd., ERBA Diagnostics, Inc., Identiv, Inc., Osiris Therapeutics, Inc., and XBiotech Inc.

PR Newswire January 18, 2016

Dr. Reddy's Announces the Relaunch of Esomeprazole Magnesium Delayed-Release Capsules, USP

Business Wire December 30, 2015

Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation of the Officers and Directors of Dr. Reddy's Laboratories Ltd. (RDY) on Behalf of Stockholders and Encourages Investors to Contact the Firm

Business Wire December 2, 2015

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Dr. Reddy's Laboratories Ltd - RDY

Accesswire November 19, 2015

Dr. Reddy's Issues a Clarification Note

Business Wire November 19, 2015

INVESTOR NOTICE: Lundin Law PC Announces Ongoing Investigation of Dr. Reddy's Laboratories Ltd. and Urges Investors to Contact the Firm

Business Wire November 18, 2015

Dr. Reddy's Announces the Completion of Fondaparinux Intellectual Property Purchase

Business Wire November 18, 2015

DR. REDDY'S INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Dr. Reddy's Laboratories Ltd. for Possible Securities Fraud

Business Wire November 13, 2015

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Claims against Dr. Reddy's Laboratories Ltd. and Advises Investors to Contact the Firm

Business Wire November 12, 2015

GPM Announces Investigation of Dr. Reddy's Laboratories, Ltd.

Business Wire November 11, 2015

INVESTOR ALERT: Khang & Khang LLP Announces An Investigation Of Claims Against Dr. Reddy's Laboratories Ltd. And Advises Investors To Contact The Firm

Business Wire November 11, 2015

Bragar Eagel & Squire, P.C. Is Investigating the Officers and Directors of Dr. Reddy's Laboratories Ltd. on Behalf of Stockholders

Business Wire November 10, 2015

SHAREHOLDER ALERT: Goldberg Law PC Announces An Investigation Of Claims Against Dr. Reddy's Laboratories Ltd. And Advises Investors To Contact The Firm

Business Wire November 10, 2015